PubMed · 15217544
Update on progressive supranuclear palsy.
Abstract
A better understanding of the challenges in the diagnosis of progressive supranuclear palsy (PSP), the most common atypical parkinsonian neurodegenerative disorder, has led to improving its diagnostic accuracy. Similarly, a better understanding of the role of tau mutations, mitochondrial complex I inhibitors, oxidative injury, and inflammation in neurodegeneration has led to an unraveling of potential risk factors for the development of PSP. These advances are explained in detail in this review.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Irene Litvan. 2004. Update on progressive supranuclear palsy.. https://doi.org/10.1007/s11910-004-0055-z
Cite the original work for its findings. Save a collection to share your selection of sources.